| Standard cholesterol tests give an
incomplete picture, leaving many people with seemingly “normal”
cholesterol numbers unaware of their true heart attack risk. The
LPP identifies hidden risk factors, giving health providers
valuable information needed to make more effective treatment
decisions. |
| Lipoproteins are like tiny beads that
carry cholesterol through the body. It is the lipoproteins
themselves, not the cholesterol in them, that leads to clogging
of the arteries and the development of cardiovascular disease. |
| Lipoprotein numbers are important
because cardiovascular risk increases as low density lipoprotein
(LDL) particle numbers increase , regardless of how much
cholesterol each lipoprotein particle contains. Cardiovascular
risk increases because large quantities of small lipoprotein
particles dramatically increase the probability of those
lipoproteins penetrating the arterial wall, where they can cause
serious damage. |
Cholesterol testing has historically
been used as the standard indicator for cardiovascular disease
classified as HDL (good) or LDL (bad). However, it is
actually the lipoprotein
particles that carry the cholesterol throughout the body,
not necessarily the cholesterol within them, that are
responsible for key steps in plaque production and the resulting
development of cardiovascular disease.
Approximately 50 percent of people
suffering from heart attacks have shown “normal” cholesterol
numbers (NIH – National Heart Blood and Lung Institute).
Now there is an advanced cholesterol testing technology which
accurately measures both the density and number of lipoprotein
particles. This test is the Lipoprotein Particle Profile™, or
LPP™. Measuring the lipoprotein subgroups is the only way to
evaluate new risk factors, which is crucial for an accurate
assessment of cardiovascular risk
– according to the National Cholesterol Education Program
(NCEP). |
| |
|
